Clinical Trial for Advanced Bile Duct Cancer
0 Visualizações
• 07/01/23
0
0
Embutir
administrator
Assinantes
Learn about a phase II multi-center study evaluating combination immunotherapy for advanced cholangiocarcinoma (bile duct cancer) with pembrolizumab and Sylatron (peginterferon alfa-2b): HCRN GI16-263. https://hoosiercancer.org/clin....ical-trials/trial/gi
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários